Clinical characteristics of Behçet syndrome in 45 children

Chen-Xi WEI, Shu-Feng ZHI, Li-Jun JIANG, Xue ZHAO, Qing-Xiao SU, Xing-Jie QI, Zan-Hua RONG

Chinese Journal of Contemporary Pediatrics ›› 2025, Vol. 27 ›› Issue (10) : 1253-1258.

PDF(574 KB)
PDF(574 KB)
Chinese Journal of Contemporary Pediatrics ›› 2025, Vol. 27 ›› Issue (10) : 1253-1258. DOI: 10.7499/j.issn.1008-8830.2503178
CLINICAL RESEARCH

Clinical characteristics of Behçet syndrome in 45 children

Author information +
History +

Abstract

Objective To study the clinical characteristics of pediatric Behçet syndrome (BS). Methods A retrospective review was conducted on the medical records of children hospitalized in the Department of Pediatrics at the Second Hospital of Hebei Medical University between December 2014 and December 2024 who met diagnostic criteria for BS. Results Among 45 children with BS, 26 (58%) were male. Oral aphthous ulcers were the most common manifestation (43/45, 96%), followed by genital ulcers (23/45, 51%) and gastrointestinal involvement (18/45, 40%). Genital ulcers were more frequent in girls, whereas ocular involvement was more common in boys (P<0.05). The pathergy test was positive in 10 (22%), and HLA-B51 was positive in 13 (29%). Fecal calprotectin (FC) was elevated in 16 (36%); gastrointestinal involvement was more frequent in children with elevated FC than in those with normal FC (P<0.05). According to the respective criteria, 17 (38%) patients met the International Study Group criteria (1990), 33 (73%) met the International Criteria for Behçet Disease (2014), and 13 (29%) met the Pediatric Behçet Disease criteria (2015). Conclusions Pediatric BS shows marked clinical heterogeneity. HLA-B51 is associated with disease susceptibility.

Key words

Behçet syndrome / Clinical characteristic / Fecal calprotectin / HLA-B51 / Child

Cite this article

Download Citations
Chen-Xi WEI , Shu-Feng ZHI , Li-Jun JIANG , et al . Clinical characteristics of Behçet syndrome in 45 children[J]. Chinese Journal of Contemporary Pediatrics. 2025, 27(10): 1253-1258 https://doi.org/10.7499/j.issn.1008-8830.2503178

References

[1]
Alibaz-Oner F, Direskeneli H. Update on the diagnosis of Behçet's disease[J]. Diagnostics (Basel), 2022, 13(1): 41. PMCID: PMC9818538. DOI: 10.3390/diagnostics13010041 .
[2]
International Team for the Revision of the International Criteria for Behçet's Disease (ITR-ICBD). The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria[J]. J Eur Acad Dermatol Venereol, 2014, 28(3): 338-347. DOI: 10.1111/jdv.12107 .
[3]
Rapo M, Molander P, af Björkesten CG, et al. Correlation of a clinical activity index in comparison to frequently measured laboratory values in inflammatory bowel disease[J]. Int J Colorectal Dis, 2025, 40(1): 45. PMCID: PMC11836091. DOI: 10.1007/s00384-025-04829-6 .
[4]
Hayashida M, Miyoshi J, Mitsui T, et al. Elevated fecal calprotectin and lactoferrin associated with small intestinal lesions in patients with Behçet disease[J]. J Gastroenterol Hepatol, 2020, 35(8): 1340-1346. DOI: 10.1111/jgh.14995 .
[5]
Kurt T, Aydın F, Sezer M, et al. Performance of diagnostic criteria in pediatric Behçet's disease[J]. Rheumatol Int, 2022, 42(1): 127-132. DOI: 10.1007/s00296-020-04777-0 .
[6]
Lee BH, Chung KB, Jang H, et al. HLA-B51 positivity correlates with symptom completeness from recurrent aphthous stomatitis to complete Behçet's disease[J]. J Dermatol, 2025, 52(6): 1001-1007. PMCID: PMC12149367. DOI: 10.1111/1346-8138.17748 .
[7]
Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease[J]. Lancet, 1990, 335(8697): 1078-1080.
[8]
Koné-Paut I, Shahram F, Darce-Bello M, et al. Consensus classification criteria for paediatric Behçet's disease from a prospective observational cohort: PEDBD[J]. Ann Rheum Dis, 2016, 75(6): 958-964. DOI: 10.1136/annrheumdis-2015-208491 .
[9]
Burns E, Cooper E, Peterson R, et al. Pediatric Behҫet disease: update in diagnosis and management[J]. Pediatr Dermatol, 2022, 39(2): 173-181. DOI: 10.1111/pde.14859 .
[10]
Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus[J]. Ann Rheum Dis, 2019, 78(9): 1151-1159. DOI: 10.1136/annrheumdis-2018-214819 .
[11]
Shiboski CH, Shiboski SC, Seror R, et al. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome: a consensus and data-driven methodology involving three international patient cohorts[J]. Arthritis Rheumatol, 2017, 69(1): 35-45. PMCID: PMC5650478. DOI: 10.1002/art.39859 .
[12]
Fazaa A, Makhlouf Y, Ben Massoud F, et al. Behçet disease: epidemiology, classification criteria and treatment modalities[J]. Expert Rev Clin Immunol, 2024, 20(12): 1437-1448. DOI: 10.1080/1744666X.2024.2388693 .
[13]
Hu D, She CH, Bao HF, et al. Clinical heterogeneity and five phenotypes identified in pediatric Behçet's syndrome: a cohort study from Shanghai Behçet's syndrome database[J]. World J Pediatr, 2024, 20(8): 801-808. PMCID: PMC11402839. DOI: 10.1007/s12519-023-00785-9 .
[14]
Zou J, Luo JF, Shen Y, et al. Distinct clinical characteristics of pediatric Behçet's syndrome: a study from a referral center in China[J]. Mod Rheumatol, 2021, 31(6): 1158-1163. DOI: 10.1080/14397595.2021.1891670 .
[15]
Hoseini Z, Rad FR, Zarei M, et al. HLA-B*51:01 in Iranian patients with Behcet uveitis syndrome[J]. Reumatol Clin (Engl Ed), 2024, 20(9): 470-475. DOI: 10.1016/j.reumae.2024.07.011 .
[16]
Santangelo A, Corsello A, Gizzi G, et al. Exploring headaches in pediatric Behçet disease: prevalence, clinical impact, and management[J]. J Clin Med, 2024, 13(13): 3659. PMCID: PMC11242365. DOI: 10.3390/jcm13133659 .
[17]
王莲, 闫淯淳, 王艺霖, 等. 儿童神经白塞综合征5例的临床特征及预后分析[J]. 中华儿科杂志, 2025, 63(1):80-83. DOI: 10.3760/cma.j.cn112140-20240810-00568 .
[18]
She CH, Cai JF, Hu D, et al. Clinical characteristics of Behçet's syndrome in Shanghai database: baseline data of a cross-sectional cohort study[J]. Int J Rheum Dis, 2024, 27(10): e15355. DOI: 10.1111/1756-185X.15355 .
[19]
Kurt T, Aydın F, Sezer M, et al. Performance of diagnostic criteria in pediatric Behçet's disease[J]. Rheumatol Int, 2022, 42(1): 127-132. DOI: 10.1007/s00296-020-04777-0 .
[20]
Lv Q, Li Y, Wei Q, et al. Autoinflammatory syndromes mimicking Behçet's disease with gastrointestinal involvement: a retrospective analysis[J]. Clin Exp Rheumatol, 2024, 42(10): 2076-2085. DOI: 10.55563/clinexprheumatol/g6729b .
[21]
Manuelyan Z, Butt E, Parupudi S. Gastrointestinal Behçet's disease: manifestations, diagnosis, and management[J]. Dis Mon, 2024, 70(1S): 101674. DOI: 10.1016/j.disamonth.2023.101674 .
[22]
葛均波, 徐永健, 王辰. 内科学[M]. 9版. 北京: 人民卫生出版社, 2018: 843-846.

Footnotes

所有作者均声明无利益冲突。

PDF(574 KB)

Accesses

Citation

Detail

Sections
Recommended

/